Pharmacogenetics- and pharmacogenomics-based rational clinical trial designs in oncology

ISSN： 1741-0541

Source： Personalized Medicine, Vol.10, Iss.8, 2013-11, pp. : 859-869

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology

By Simon Richard

Personalized Medicine, Vol. 7, Iss. 1, 2010-01 ,pp. : 33-47

Future Medicine

Access to resources Recommend Favorite

Impact of Pharmacogenomics on Clinical Practice in Oncology

By Marsh Sharon

Molecular Diagnosis & Therapy, Vol. 11, Iss. 2, 2007-01 ,pp. : 79-82

Adis International

Access to resources Recommend Favorite

Principles of Pharmacogenetics and Pharmacogenomics

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 1, 2012-07 ,pp. : 14-15

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improving Clinical Trial Recruitment: Experience of a Tertiary Renal Oncology Centre

Oncology, Vol. 85, Iss. 5, 2013-11 ,pp. : 297-298

Karger

Access to resources Recommend Favorite

Rational Development of Peptide Vaccination in Clinical Oncology. Concerning Jäger E, et al.: Peptide vaccination in clinical oncology. Onkologie 2000;23:410–415.

Oncology Research and Treatment, Vol. 24, Iss. 2, 2001-05 ,pp. : 174-174

Karger

Access to resources Recommend Favorite